Phase I Trial of Pomalidomide for Patients With Relapsed/Refractory Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 28 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 28 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology